Management attributes the more than 350% revenue growth in 2018 from the less than $300,000 in revenue reported in 2017 to the success of the company’s EVERx CBD Sports Beverage.
Read More
After unanimous approval by the house, Senate Bill 868 has proceeded to the desk of Oklahoma Governor Kevin Stitt, which would allow for the commercial production of industrial hemp.
Read More
Following a thorough selection process, the Company’s Audit Committee has concluded that Deloitte is best positioned to meet the evolving needs of CV Sciences.
Read More
The cannabis extract research and development targets four specific health issues: Chronic Obstructive Pulmonary Disease (COPD); Type 2 Diabetes; Cancer Pain Management, and Epilepsy.
Read More
The Board of Directors has appointed Andrew G. Long as Chief Executive Officer, effective immediately.
Read More
Get stock alerts, news & related alerts straight to your inbox!